We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Acumen® eX3 Speeds Up Cytotoxicity Profiling
Product News

Acumen® eX3 Speeds Up Cytotoxicity Profiling

Acumen® eX3 Speeds Up Cytotoxicity Profiling
Product News

Acumen® eX3 Speeds Up Cytotoxicity Profiling


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Acumen® eX3 Speeds Up Cytotoxicity Profiling"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

TTP LabTech has announced a number of high throughput platform solutions for the study of cytotoxicity. The platforms utilize the successful Acumen® eX3 fluorescence microplate cytometer and a number of new solutions for toxicity profiling developed by Invitrogen, a division of Life Technologies Corporation.

This announcement comes at a time when such cellular based assays are being increasingly recommended as the first approach in determining drug on- and off- target effects.

The Acumen® eX3 laser scanning cytometer is an ultra-high throughput system for cell-based screening that offers enhanced multiplexing capability to maximize data content and the rapid generation of robust data sets when deployed with ready-to-use Molecular Probes® kits and reagents from Invitrogen. With these Molecular Probes® high-content screening products, a number of cytotoxic phenomena can be analyzed including: cell viability, DNA damage and cell cycle processes such as mitosis.

The strength of the Acumen® eX3 platform combined with these Invitrogen high content screening (HCS) products enables the high-throughput analysis of a wide variety of toxicity parameters.
Advertisement